|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's range||24.22 - 25.71|
|52-week range||13.19 - 59.50|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
WILIMINGTON, Del., November 16, 2022--Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022.
RALEIGH, N.C., October 28, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2023 financial results after the close of market trading on Thursday, December 8, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results s
WILMINGTON, Del., September 22, 2022--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021.